News

Alder Hey children’s hospital and Proveca Ltd are joining forces with the aim of improving medicines for children and young people. The new collaborative partnership plans to provide the best pharmaceutical treatments for children by identi...

Lipid reformulation of anti-inflammatory compound MT1980 for POCD accelerating into clinic in 2022 Manchester, UK, Dec 14, 2021: Monument Therapeutics, a stratified medicine company, today announced it has raised an additional £0....

Alderley Park, Cheshire Infex Therapeutics has today announced a deal with Colibri Scientific, to provide logistics and sample operational services for Infex’s RESP-X program. RESP-X is an anti-virulence therapy in-licensed from Japane...

With access to leading hepatologists, biopsy theatres, fibroscans at specialist sites and ongoing mass screening programmes Panthera can help pharma and CROs find a treatment for this increasingly common, progressive, and life-threatening diseases...

Alderley Park, Cheshire –  One of the UK’s leading infectious disease biotech companies has announced a breakthrough in laboratory trials of a new drug to treat COVID-19 and new variants of the disease, such as the Omicron variant...